Developments in single photon emission computed tomography and PET-based HER2 molecular imaging for...
Developments in single photon emission computed tomography and PET-based HER2 molecular imaging for breast cancer
About this item
Full title
Author / Creator
Publisher
London: Informa Healthcare
Journal title
Language
English
Formats
Publication information
Publisher
London: Informa Healthcare
Subjects
More information
Scope and Contents
Contents
Molecular imagings of hEGF receptor 2 (HER2) using radiolabeled tracers has the potential to determine the extent of HER2-positive disease and could be of great clinical value. HER2 overexpression affects 20-25% of breast cancer patients, conferring a worse prognosis. HER2 status determines choice and response to therapy but can change in response...
Alternative Titles
Full title
Developments in single photon emission computed tomography and PET-based HER2 molecular imaging for breast cancer
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1315884186
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1315884186
Other Identifiers
ISSN
1473-7140
E-ISSN
1744-8328
DOI
10.1586/era.13.11
